Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus' Lateral Body Protein.

Giotis ES. et al, (2020), Biomedicines, 8

Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.

Laidlaw SM. et al, (2017), Gastroenterology, 153, 566 - 578.e5

MAIT cells are activated during human viral infections.

van Wilgenburg B. et al, (2016), Nat commun, 7

Immune control and failure in HCV infection--tipping the balance.

Dustin LB. et al, (2014), J leukoc biol, 96, 535 - 548

Construction of Deletion-knockout Mutant Fowlpox Virus (FWPV).

Laidlaw SM. and Skinner MA., (2014), Bio protoc, 4

Interferon lambda: opportunities, risks, and uncertainties in the fight against HCV.

Laidlaw SM. and Dustin LB., (2014), Front immunol, 5

Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response.

Buttigieg K. et al, (2013), J virol, 87, 5028 - 5040

Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon.

Laidlaw SM. et al, (2013), J virol, 87, 5041 - 5052

Protein-protein interactions of fowlpox virus.

Laidlaw SM., (2010)

Retention of 1.2 kbp of 'novel' genomic sequence in two European field isolates and some vaccine strains of Fowlpox virus extends open reading frame fpv241.

Jarmin SA. et al, (2006), J gen virol, 87, 3545 - 3549

Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.

Imoukhuede EB. et al, (2006), Vaccine, 24, 6526 - 6533

Avipoxvirus phylogenetics: identification of a PCR length polymorphism that discriminates between the two major clades.

Jarmin S. et al, (2006), J gen virol, 87, 2191 - 2201

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.

Webster DP. et al, (2006), Vaccine, 24, 3026 - 3034

In vitro expression and analysis of secreted fowlpox virus CC chemokine-like proteins Fpv060, Fpv061, Fpv116 and Fpv121.

Jeshtadi A. et al, (2005), Arch virol, 150, 1745 - 1762

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.

Webster DP. et al, (2005), Proc natl acad sci u s a, 102, 4836 - 4841

Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.

Skinner MA. et al, (2005), Expert rev vaccines, 4, 63 - 76

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.

Anderson RJ. et al, (2004), J immunol, 172, 3094 - 3100

Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of Fowlpox virus, with those of virulent American and European viruses.

Laidlaw SM. and Skinner MA., (2004), J gen virol, 85, 305 - 322

Identification and characterization of three immunodominant structural proteins of fowlpox virus.

Boulanger D. et al, (2002), J virol, 76, 9844 - 9855

Induction of a strong HIV-specific CD8+ T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide.

Vázquez Blomquist D. et al, (2002), Viral immunol, 15, 337 - 356

Load More

Include forthcoming?